14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients

Figure 6

Comparison of the predictive value of the 14-CpG-based signature with AJCC TNM stage and other CpG-based signatures from TCGA. Time-dependent ROC analysis was used to evaluate the predictive value among the three signatures in predicting 1-year (a), 3-year (b), and 5-year (c) overall survival time.

(a)

(b)

(c)